Literature DB >> 16769763

Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells.

Jens Koerner1, Dobrila Nesic, Jose Diaz Romero, Walter Brehm, Pierre Mainil-Varlet, Shawn Patrick Grogan.   

Abstract

Fibroblast-like cells isolated from peripheral blood of human, canine, guinea pig, and rat have been demonstrated to possess the capacity to differentiate into several mesenchymal lineages. The aim of this work was to investigate the possibility of isolating pluripotent precursor cells from equine peripheral blood and compare them with equine bone marrow-derived mesenchymal stem cells. Human mesenchymal stem cells (MSCs) were used as a control for cell multipotency assessment. Venous blood (n = 33) and bone marrow (n = 5) were obtained from adult horses. Mononuclear cells were obtained by Ficoll gradient centrifugation and cultured in monolayer, and adherent fibroblast-like cells were tested for their differentiation potential. Chondrogenic differentiation was performed in serum-free medium in pellet cultures as a three-dimensional model, whereas osteogenic and adipogenic differentiation were induced in monolayer culture. Evidence for differentiation was made via biochemical, histological, and reverse transcription-polymerase chain reaction evaluations. Fibroblast-like cells were observed on day 10 in 12 out of 33 samples and were allowed to proliferate until confluence. Equine peripheral blood-derived cells had osteogenic and adipogenic differentiation capacities comparable to cells derived from bone marrow. Both cell types showed a limited capacity to produce lipid droplets compared to human MSCs. This result may be due to the assay conditions, which are established for human MSCs from bone marrow and may not be optimal for equine progenitor cells. Bone marrow-derived equine and human MSCs could be induced to develop cartilage, whereas equine peripheral blood progenitors did not show any capacity to produce cartilage at the histological level. In conclusion, equine peripheral blood-derived fibroblast-like cells can differentiate into distinct mesenchymal lineages but have less multipotency than bone marrow-derived MSCs under the conditions used in this study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769763     DOI: 10.1634/stemcells.2005-0264

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  33 in total

1.  Osteogenic and adipogenic differentiation potential of an immortalized fibroblast-like cell line derived from porcine peripheral blood.

Authors:  Xiuqing Wang; Daphne Moutsoglou
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-12       Impact factor: 2.416

2.  Size-sieved subpopulations of mesenchymal stem cells from intervascular and perivascular equine umbilical cord matrix.

Authors:  B Corradetti; A Lange-Consiglio; M Barucca; F Cremonesi; D Bizzaro
Journal:  Cell Prolif       Date:  2011-06-06       Impact factor: 6.831

3.  Noninvasive multimodal evaluation of bioengineered cartilage constructs combining time-resolved fluorescence and ultrasound imaging.

Authors:  Brett Z Fite; Martin Decaris; Yinghua Sun; Yang Sun; Adrian Lam; Clark K L Ho; J Kent Leach; Laura Marcu
Journal:  Tissue Eng Part C Methods       Date:  2011-02-08       Impact factor: 3.056

4.  Tat-MyoD fused proteins, together with C2c12 conditioned medium, are able to induce equine adult mesenchimal stem cells towards the myogenic fate.

Authors:  Marco Patruno; Chiara Gomiero; Roberta Sacchetto; Ohad Topel; Alessandro Negro; Tiziana Martinello
Journal:  Vet Res Commun       Date:  2017-06-06       Impact factor: 2.459

5.  Tenogenic induction of equine mesenchymal stem cells by means of growth factors and low-level laser technology.

Authors:  Chiara Gomiero; Giulia Bertolutti; Tiziana Martinello; Nathalie Van Bruaene; Sarah Y Broeckx; Marco Patruno; Jan H Spaas
Journal:  Vet Res Commun       Date:  2016-01-13       Impact factor: 2.459

6.  Comparative study of biological characteristics of mesenchymal stem cells isolated from mouse bone marrow and peripheral blood.

Authors:  Ahmed Lotfy; Yasser M El-Sherbiny; Richard Cuthbert; Elena Jones; Ahmed Badawy
Journal:  Biomed Rep       Date:  2019-09-02

7.  Mesenchymal stem cells from the retropatellar fat pad and peripheral blood stimulate ACL fibroblast migration, proliferation, and collagen gene expression.

Authors:  B L Proffen; C M Haslauer; C E Harris; M M Murray
Journal:  Connect Tissue Res       Date:  2012-08-23       Impact factor: 3.417

8.  Isolation, growth and differentiation of equine mesenchymal stem cells: effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor.

Authors:  Silvia Colleoni; Emanuela Bottani; Irene Tessaro; Gaetano Mari; Barbara Merlo; Noemi Romagnoli; Alessandro Spadari; Cesare Galli; Giovanna Lazzari
Journal:  Vet Res Commun       Date:  2009-12       Impact factor: 2.459

9.  Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow.

Authors:  Martin A Vidal; Sandra O Robinson; Mandi J Lopez; Daniel B Paulsen; Olga Borkhsenious; Jill R Johnson; Rustin M Moore; Jeffrey M Gimble
Journal:  Vet Surg       Date:  2008-12       Impact factor: 1.495

Review 10.  Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine.

Authors:  Thomas G Koch; Lise C Berg; Dean H Betts
Journal:  Can Vet J       Date:  2009-02       Impact factor: 1.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.